Skip to content

Comparison of the effectiveness of ozone and corticosteroid injections in the treatment of CTS

Comparison of the effectiveness of local corticosteroid injection and local ozone injection in patients with carpal tunnel syndrome (CTS)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210920052535N1
Enrollment
46
Registered
2022-06-26
Start date
2021-05-22
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: First Intervention group: corticosteroid (40mg Triamcinolone) injection under the ultrasound-guide around the median nerve. Intervention 2: Second Intervention group: ozone (Ozone at

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years with signs and symptoms of carpal tunnel syndrome confirmed by Electrodiagnostic study and have mild to moderate CTS according to it.

Exclusion criteria

Exclusion criteria: Age under 18 years Severe carpal tunnel syndrome Presence of underlying diseases such as diabetes, rheumatoid arthritis, thyroid disease and previous history of trauma Presence of thenar atrophy and peripheral nerve lesions of the upper extremity, polyneuropathy and radiculopathy Pregnancy, history of G6PD deficiency, thrombocytopenia, severe cardiovascular instability, people are receiving ACE-I History of injection or using a splint during the past 6 months or any previous surgery on the carpal tunnel

Design outcomes

Primary

MeasureTime frame
The severity of symptoms and functional limitations. Timepoint: Zero and 8th week. Method of measurement: Boston questionnaire was applied.;The severity of symptoms. Timepoint: Zero and 8th week. Method of measurement: Visual Analog Scale(VAS).;Electrodiagnostic criteria. Timepoint: Zero and 8th week. Method of measurement: EMG-NCS device was applied.;Sonographic criteria. Timepoint: Zero and 8th week. Method of measurement: Sonographic device was applied.

Secondary

MeasureTime frame
Side effects. Timepoint: 8th week. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Hesam

Yazd University of Medical Sciences

f.hesam@rocketmail.com+98 35 3822 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026